Skip to main content
Premium Trial:

Request an Annual Quote

Anderson Forschung to Develop Assay for Biomarker Quantitation for BiOasis

NEW YORK (GenomeWeb News) – BiOasis said today that it has tapped the Anderson Forschung Group to develop a new proteomics assay for diagnosing Alzheimer’s disease.
Under the agreement, Anderson Forschung will develop an assay using a technique called Stable Isotope Standards and Capture by Anti-Peptide Antibodies, a proteomics platform aimed at biomarker quantification and qualification.  
The SISCAPA technique was developed to measure protein levels in human plasma and is based on immunoaffinity enrichment of peptide surrogates of biomarker proteins and their identification by mass spectrometry.
The company said that the technique improves standard immunoassays because the analytes are identified by mass spectrometry, the assay detects peptide surrogates rather than protein targets, allowing for less variability due to degradation, and it is less subject to interference caused by antibodies that bind the analyte because those are destroyed during the sample preparation step.
BiOasis, based in Surrey, BC, will use SISCAPA as a second, independent method for quantification of p97 in human plasma in parallel with a sandwich immunoassay, which could add confidence for qualification of the biomarker for Alzheimer’s disease.
Financial terms of the agreement were not released.
Leigh Anderson, the founder of Anderson Forschung, is a member of BiOasis's scientific advisory board. 

The Scan

Shape of Them All

According to BBC News, researchers have developed a protein structure database that includes much of the human proteome.

For Flu and More

The Wall Street Journal reports that several vaccine developers are working on mRNA-based vaccines for influenza.

To Boost Women

China's Ministry of Science and Technology aims to boost the number of female researchers through a new policy, reports the South China Morning Post.

Science Papers Describe Approach to Predict Chemotherapeutic Response, Role of Transcriptional Noise

In Science this week: neural network to predict chemotherapeutic response in cancer patients, and more.